Warning Letter to RemedyMart
Unspecified. See RemedyMart's company page.
On May 29, 2018, FDA's CDER sent RemedyMart a warning letter citing unapproved new drug, labeling.
- Letter date: May 29, 2018
- Issued by: CDER
- Closeout: —
The Letter
As posted on FDA.gov ↗; cited 21 CFR sections link to their page.FDA's site did not return the letter just now. Read it on FDA.gov ↗
Recent Letters Citing Unapproved new drug
See them all- RonanRx, Inc. dba RonanRxOct 30, 2026 · CDER · Unapproved new drug
- Bella’s Nutri Shop Inc.Oct 26, 2026 · CDER · Unapproved new drug, Labeling
- Jing Cheong Asia Inc. dba New York Tong Ren TangOct 26, 2026 · CDER · Unapproved new drug
- NatuzemOct 26, 2026 · CDER · Unapproved new drug
- New Green Nutrition Inc.Oct 26, 2026 · CDER · Unapproved new drug, Labeling
Record
- Recipient
- —
- FDA site ID (FEI)
- —
- Cited
Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters